Aperio, digital-pathology innovator, raises $11M
Aperio, a Vista, Calif., maker of systems that digitize medical images for use in the diagnosis of disease, raised $10.6 million from existing investors. It last raised $17 million in a second round of funding in Nov. 2005, and has now garnered a total of $33 million in equity capital. The company’s release is here.
Aperio makes systems that digitally scan microscope slides of tissue samples in high resolution and then allow diagnostic specialists, or pathologists, to view and analyze them in detail. The systems are currently offered for research purposes only, as they have not been cleared or approved by the FDA for patient care.
The round was led by Galen Partners and Advanced Technology Ventures, with participation by other existing investors.
Next Story: Jazz Pharma takes it on the chin, raises less-than-expected $108M in IPO
Previous Story: INI Power Sytems raises $4M for methanol-powered fuel cell
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.